BFLY Stock Overview
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.
Butterfly Network Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$3.07|
|52 Week High||US$14.71|
|52 Week Low||US$2.31|
|1 Month Change||-4.06%|
|3 Month Change||-36.57%|
|1 Year Change||-78.47%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-68.99%|
Recent News & Updates
|BFLY||US Medical Equipment||US Market|
Return vs Industry: BFLY underperformed the US Medical Equipment industry which returned -24% over the past year.
Return vs Market: BFLY underperformed the US Market which returned -18.8% over the past year.
|BFLY Average Weekly Movement||12.1%|
|Medical Equipment Industry Average Movement||10.4%|
|Market Average Movement||8.0%|
|10% most volatile stocks in US Market||16.8%|
|10% least volatile stocks in US Market||3.2%|
Stable Share Price: BFLY is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: BFLY's weekly volatility (12%) has been stable over the past year.
About the Company
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smartphone, tablet, and hospital computer system; and Butterfly Blueprint, a system-wide ultrasound platform with Compass software that integrates into a healthcare system’s clinical and administrative infrastructure. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel.
Butterfly Network Fundamentals Summary
|BFLY fundamental statistics|
Is BFLY overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BFLY income statement (TTM)|
|Cost of Revenue||US$32.17m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.38|
|Net Profit Margin||-115.98%|
How did BFLY perform over the long term?See historical performance and comparison
Is BFLY undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 0/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BFLY?
Other financial metrics that can be useful for relative valuation.
|What is BFLY's n/a Ratio?|
Price to Sales Ratio vs Peers
How does BFLY's PS Ratio compare to its peers?
|BFLY PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
ATEC Alphatec Holdings
HLTH Cue Health
BFLY Butterfly Network
Price-To-Sales vs Peers: BFLY is expensive based on its Price-To-Sales Ratio (9.3x) compared to the peer average (2.2x).
Price to Earnings Ratio vs Industry
How does BFLY's PE Ratio compare vs other companies in the US Medical Equipment Industry?
Price-To-Sales vs Industry: BFLY is expensive based on its Price-To-Sales Ratio (9.3x) compared to the US Medical Equipment industry average (4x)
Price to Sales Ratio vs Fair Ratio
What is BFLY's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||9.3x|
|Fair PS Ratio||5.6x|
Price-To-Sales vs Fair Ratio: BFLY is expensive based on its Price-To-Sales Ratio (9.3x) compared to the estimated Fair Price-To-Sales Ratio (5.6x).
Share Price vs Fair Value
What is the Fair Price of BFLY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate BFLY's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate BFLY's fair value for valuation analysis.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate BFLY's PEG Ratio to determine if it is good value.
Discover undervalued companies
How is Butterfly Network forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if BFLY's forecast earnings growth is above the savings rate (1.9%).
Earnings vs Market: Insufficient data to determine if BFLY's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if BFLY's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: BFLY's revenue (29.8% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: BFLY's revenue (29.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BFLY's Return on Equity is forecast to be high in 3 years time
Discover growth companies
How has Butterfly Network performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: BFLY is currently unprofitable.
Growing Profit Margin: BFLY is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: BFLY is unprofitable, but has reduced losses over the past 5 years at a rate of 5.2% per year.
Accelerating Growth: Unable to compare BFLY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BFLY is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.9%).
Return on Equity
High ROE: BFLY has a negative Return on Equity (-18.46%), as it is currently unprofitable.
Discover strong past performing companies
How is Butterfly Network's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: BFLY's short term assets ($474.3M) exceed its short term liabilities ($50.7M).
Long Term Liabilities: BFLY's short term assets ($474.3M) exceed its long term liabilities ($72.0M).
Debt to Equity History and Analysis
Debt Level: BFLY is debt free.
Reducing Debt: BFLY had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BFLY has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: BFLY has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 27.8% each year.
Discover healthy companies
What is Butterfly Network current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate BFLY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BFLY's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if BFLY's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BFLY's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as BFLY has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Todd Fruchterman (51 yo)
Dr. Todd M. Fruchterman, M.D, Ph D., serves as Independent Director at Spindletop Health Acquisition Corp. since November 8, 2021. He has been the Chief Executive Officer and President of Butterfly Network...
CEO Compensation Analysis
Compensation vs Market: Todd's total compensation ($USD34.88M) is above average for companies of similar size in the US market ($USD4.00M).
Compensation vs Earnings: Insufficient data to compare Todd's compensation with company performance.
Experienced Management: BFLY's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Experienced Board: BFLY's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: BFLY insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4%.
Butterfly Network, Inc.'s employee growth, exchange listings and data sources
- Name: Butterfly Network, Inc.
- Ticker: BFLY
- Exchange: NYSE
- Founded: 2011
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: US$610.797m
- Shares outstanding: 198.96m
- Website: https://www.butterflynetwork.com
Number of Employees
- Butterfly Network, Inc.
- 530 Old Whitfield Street
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/28 00:00|
|End of Day Share Price||2022/06/28 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.